Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% UpsideBenzinga • 11/08/24
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS)PRNewsWire • 09/25/24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024GlobeNewsWire • 08/14/24
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 06/28/24
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerGlobeNewsWire • 06/10/24
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/30/24
Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/14/24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024GlobeNewsWire • 05/14/24
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/09/24
Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect?Zacks Investment Research • 04/12/24
All You Need to Know About Pyxis Oncology (PYXS) Rating Upgrade to BuyZacks Investment Research • 03/26/24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023GlobeNewsWire • 03/21/24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFAGlobeNewsWire • 03/13/24
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual MeetingGlobeNewsWire • 03/05/24
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate UpdateGlobeNewsWire • 11/07/23
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023GlobeNewsWire • 09/27/23
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ: PYXS)PRNewsWire • 09/21/23